Safer injecting education for HIV prevention within a medically supervised safer injecting facility

International Journal of Drug Policy

Volumn 16, Issue 4, 2005, Pages 281-284

  Wood, Evan ^a,b   Tyndall, Mark W ^a,b   Stoltz, Jo Anne ^a   Small, Will ^a   Zhang, Ruth ^a   O'Connell, Jacqueline ^a   Montaner, Julio S G ^a,b   Kerr, Thomas ^a  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

HIV incidence; Injection drug users; Supervised injecting facility

Indexed keywords

ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; HEALTH CARE FACILITY; HEALTH EDUCATION; HEALTH PROMOTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION CONTROL; MALE; NEEDLESTICK INJURY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SAFETY;

EID: 27644579860     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2005.07.004     Document Type: Article

References (20)

1. Broadhead, R. S., Kerr, T. H., Grand, J., & Altice, F. L. (2002). Safer injection facilities in North America: Their place in public policy and health initiatives. Journal of Drug Issues, 32(1), 329-355.
2. Des Jarlais, D. C., & Friedman, S. R. (1998). Fifteen years of research on preventing HIV infection among injecting drag users: What we have learned, what we have not learned, what we have done, what we have not done. Public Health Reports, 113(Suppl. 1), 182-188.
3. Des Jarlais, D. C., Marmor, M., Paone, D., Titus, S., Shi, Q., Perlis, T, et al. (1996). HIV incidence among injecting drag users in New York City syringe-exchange programmes. Lancet, 348(9033), 987-991.
4. Des Jarlais, D. C., Paone, D., Milliken, J., Turner, C. F., Miller, H., Gribble, J., et al. (1999). Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: A quasi-randomised trial. Lancet, 353(9165), 1657-1661.
5. Dolan, K., Kimber, J., Fry, C., Fitzgerald, J., MacDonald, D., & Trautmann, F. (2000). Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug and Alcohol Review, 19, 337-346.
6. Hagan, H., McGough, J., Thiede, H., Weiss, N. S., & Hopkins, S. (1999). Syringe exchange and risk of infection with hepatitis B and C viruses. American Journal of Epidemiology, 149, 203-213.
7. Kerr, T., Wodak, A., Elliot, L., Montaner, J., & Wood, E. (2004). Opiod substitution therapy and HIV/AIDS treatment and prevention. Lancet, 364(9449), 1918-1919.
8. Kerr, T., Wood, E., Small, D., Palepu, A., & Tyndall, M. W. (2003). Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside. Canadian Medical Association Journal, 169(8), 759-763.
9. Kral, A., Bluthenthal, R., Erringer, E., Lorvick, J., & Edlin, B. (1999). Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction, 94(5), 675-683.
10. Krai, A., Bluthenthal, R., Lorvick, J., Gee, L., Bacchetti, P., & Edlin, B. (2001). Sexual transmission of HIV-1 among injection drug users in San Francisco USA: Risk-factor analysis. Lancet, 357(9266), 1397-1401.
11. O'Connell, J. M., Kerr, T., Li, K., Tyndall, M. W., Hogg, R. S., Montaner, J. S., et al. Requiring help injecting independently predicts incident HIV infection among injection drug users. Journal of Acquired Immune Deficiency Syndromes, in press.
12. Strathdee, S., Galai, N., Safaiean, M., Celentano, D., Vlahov, D., Johnson, L., et al. (2001). Sex differences in risk factors for HIV seroconversion among injection drug users: A 10-year perspective. Archives of Internal Medicine, 161, 1281-1288.
13. Tyndall, M., Currie, S., Spittal, P., Li, K., Wood, E., O'Shaughnessy, M., et al. (2003). Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS, 17(6), 887-893.
14. Vlahov, D., Fuller, C. M., Ompad, D. C., Galea, S., & Des Jarlais, D. C. (2004). Updating the infection risk reduction hierarchy: Preventing transition into injection. Journal of Urban Health, 81(1), 14-19.
15. Wood, E., Kerr, T., Lloyd-Smith, E., Buchner, C., Marsh, D., Montaner, J., et al. (2004). Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduction Journal, 1(1), 9.
16. Wood, E., Kerr, T., Montaner, J., Strathdee, S., Wodak, A., Hankins, C., et al. (2004). Rationale for evaluating North America's first medically supervised safer-injecting facility. Lancet Infectious Diseases, 4, 301-306.
17. Wood, E., Spittal, P., Kerr, T., Small, W., Tyndall, M., O'Shaughnessy, M., et al. (2003). Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: Implications for HIV prevention. Canadian Journal of Public Health, 94(5), 355-359.
18. Wood, E., Tyndall, M., Spittal, P., Li, K., Hogg, R., Montaner, J., et al. (2002). Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS, 16(6), 941-943.
19. Wood, E., Tyndall, M., Spittal, P., Li, K., Hogg, R., O'Shaughnessy, M., et al. (2002). Needle exchange and difficulty with needle access during an ongoing HIV epidemic. International Journal of Drug Policy, 13(2), 95-102.
20. Wright, N. M., & Tompkins, C. N. (2004). Supervised Injecting centres. British Medical Journal, 328, 100-102.